Therapeutic Targeting of the Microbiome for Neurodevelopmental Disorders

(57:5)

Microbiota-targeting agents for Parkinson’s disease

(1:52)

Targeting the gut microbiota to reduce the risk of disease. Where are we now? - Hania Szajewska

(17:36)

Gut Microbiota as a Participant and Therapeutic Target in Atherosclerosis and Vascular Inflammation

(30:23)

ILSI Europe: AM2016: Targeting Microbiota – A new science in nutrition (Boindala Sesikeran)

(11:23)

WEBINAR: Targeting the brain-gut-microbiome axis by ImmuneBiotics™

(49:21)

Potential of targeting the gut microbiome to treat Alzheimer's disease

(1:14)

Children's gut bacteria may hold the key to diarrhea treatment

(44)

Multi-Microbiome Effects: Probiotic Strategies to Target Next-Generation Microbes

(18:39)

Lecture: Microbiota-targeted Therapies from Probiotics to Transplants: New Regulatory Challenges

(1:30:5)

The Microbiome Gut-Brain Connection: Depression and Anxiety

(57:21)

Drugs targeting the microbiome are already on sale

(1:2)

Targeting the microbiota-gut-brain axis: Towards evidence based approaches for metabolic and ment...

(37:8)

The Microbiome and ASD

(59:3)

Elucidating Mechanisms underlying Microbiome Regulation of Immune Responses by Dr. Kathy McCoy

(56:2)

Exclusive interview Targeting Microbiota H Blottière

(3:47)

The Influence of the Gut Microbiome on Response to Anti-PD-1 Therapy in Melanoma

(2:38)

The Human Microbiome | Illumina Webinar

(58:45)

Microbiota and Vaccines - Eric Brown

(23:7)